Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Stock Upgrades: Eli Lilly Coming Up Roses


Wall Street ratings agencies set the tone for today's stock market.

A recently unearthed video showed a geeky Jon Hamm, looking nothing like the Don Draper lady-killer who returned to our TV screens last night, getting nowhere with the ladies in 1996. That was also the year of Alan Greenspan's "irrational exuberance" in equities and, alas, the S&P 500 Index (INDEXSP:.INX) similarly looks nothing like it did back then. This, after both the benchmark bourse and Nasdaq (INDEXNASDAQ:.IXIC) endured their single worst week in almost two years. (Thankfully, IAC/InterActiveCorp (NASDAQ:IACI), up 0.66% even in Friday's market bloodbath after buying more of Tinder, is still trying its best to play matchmaker for Mr. Hamm and others.) Twitter's (NYSE:TWTR) bluebird slid 7.2%, but the news was better for Dove soap owner Unilever (NYSE:UN). It gained 4.14% to an all-time high after, well, dovish comments from the Fed head. An eagle-eyed editor failed to watch like a hawk and was taken in by a spoof story about the Vatican. Yet the Buenos Aires-born pontiff had the last laugh as his hometown's Telecom Argentina (NYSE:TEO) advanced 4.36% amid the downturn. And ahead of tomorrow's IRS deadline, H&R Block (NYSE:HRB) slumped 6.3%. There is no evading the truth -- these are taxing times for Wall Street's bull.
Today in economics, business inventories for February are out at 10:00 a.m. EDT. On the corporate front, the first full week of first-quarter earnings commences with Citigroup (NYSE:C), JB Hunt Transport (NASDAQ:JBHT), and M&T Bank (NYSE:MTB) all releasing results.
Acorda Therapeutics (NASDAQ:ACOR): Shares get upgraded to Outperform from Perform at FBR Capital, which takes its target price to $47 from $30. Plumiaz, to treat epilepsy seizures, offers promise, the bank believes.
bebe stores (NASDAQ:BEBE): The stock is now Buy from Neutral at Janney amid improving same-store sales.
Bloomin' Brands (NASDAQ:BLMN): Deutsche Bank hoists the owner of Outback Steakhouse to Buy from Hold.
Boston Scientific (NYSE:BSX): Bank of America Merrill Lynch the medical device maker to Buy from Neutral.
BP Plc (NYSE:BP): The oil giant gets upgraded to Buy from Hold at Canaccord Genuity.
Credit Card CompaniesMasterCard (NYSE:MA) and Visa (NYSE:V) are each upgraded to Outperform from Neutral at Robert W. Baird, which sees an attractive entry point after shares recently pulled back. Its respective price objectives are $83 and $245.
Eaton Vance (NYSE:EV): The stock is now Neutral from Sell at Citigroup.
Eli Lilly (NYSE:LLY): Jefferies hoists the pharmaceutical firm to Hold from Underperform.
F5 Networks (NASDAQ:FFIV): Shares are taken to Buy from Hold at Stifel.
Hyatt Hotels (NYSE:H): FBR Capital increases the accommodation outfit to Outperform from Perform. Its price objective, previously $55, is now $62.
Lincoln National (NYSE:LNC): LNC is lifted to Strong Buy from Outperform at Raymond James.
Palo Alto Networks (NYSE:PANW): Shares are boosted to Overweight from Equal Weight by Barclays.
PriceSmart (NASDAQ:PSMT): Roth Capital raises its recommendation to Buy from Neutral.
TD Ameritrade (NYSE:AMTD): The stock is taken to Outperform from Perform at Keefe Bruyette.
Yahoo (NASDAQ:YHOO): Shares are now Buy from Neutral with an amended $40 price objective at SunTrust.
VMware (NYSE:VMW): Credit Agricole increases its opinion to Outperform from Underperform.
Zimmer (NYSE:ZMH): The stock is now Neutral from Reduce at SunTrust.
Also see:

New Stock Coverage: 3D Systems No Longer a License to Print Money

Stock Downgrades: Microsoft Has Tech Investors Jumping Out of Windows
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos